Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Therapy in Neovascular AMD
NCT00376701Phase 2Completed
- Start
- Sep 2006
- Primary completion
- Apr 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in age-related macular degeneration (AMD). Started Sep 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00376701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00376701.